CALL FOR PROPOSALS “Business Service Center” IMPORTANT DATES: Application start d...November 15, 2016
“ One company, with three areas of expertise,
each with dedicated leadership & resources –
delivering a continuum of solutions.”
“ We share your drive to make things better.
So we built a better way to get your medtech innovation
to the right people in Europe.”
We guide your medtech innovation through the entire medtech lifecycle.
Whether an established or a start-up company, you need one partner that can guide you.
medeuronet played a part in two of the biggest exits in ophthalmology in the past 10 years – WaveTec Vision Systems and IntraLase.
The path is the same for any medical device. We bring focus, consistency and efficiency to the commercialization process.
A controlled process. The best way to change a market is to correctly target, prove your value, then expand.
We get your technology into the right hands at the right time, with expert training and support.
Pegged at EUR 55 billion+, the EU medical device market is second only to that of the United States, with a shorter regulatory process that allows for market introduction to test product interest and market adoption.
Europe is not one market – it’s a collection of culturally diverse markets, each with its own regulatory requirements and commercialization process. You also face a changing regulatory landscape, increasing reimbursement and pricing pressures in a challenging environment.
Grow awareness of the role sleep apnea potentially played in heart failure/Promote SERVE-HF study
Support the announcement of successful first in human implantation of bioabsorbable heart conduit
EU Market Assessment, development of EU commercial model & initial commercial rollout
Beta commercial evaluation of proposed EU business model
Rescue 1,000 patient registry study
Expand EU commercial user base
Assist with CE Marking & 1st prospective clinical study benchmarking against standard of care dry eye tests
medeuronet’s network provides our clients with robust expertise in the key areas of reimbursement, regulatory and clinical study management along with a country commercial network that ensures consistent market introduction.
The latest news from medeuronet
By Lauretta Ihonor, MBBS The past 10 years have brought a remarkable shift in the wa...November 15, 2016
By Ali Warner Only 10 per cent of medtech startups are founded by women. But those th...October 13, 2016